Dynamic Light
Convertible Note in 2022
Dynamic Light, founded in May 2018 and based in Austin, Texas, specializes in the development of innovative blood flow imaging technology. The company's mission is to enhance patient care and reduce healthcare costs through real-time, continuous, and quantitative visualization of blood flow in living tissues. Dynamic Light's technology allows surgeons to obtain high-resolution images of blood flow and perfusion without the need for dyes or procedural interruptions. This capability supports improved decision-making during surgical procedures, ultimately leading to better outcomes for patients.
Galen Data
Series A in 2021
Galen Data, Inc. is a healthcare technology company based in Houston, Texas, founded in 2016. It offers a configurable and scalable software platform designed for medical devices, enabling them to centralize and securely store data while leveraging cloud technologies. The platform facilitates data visualization and analytics, integrating seamlessly with major electronic health record systems. By providing a turn-key solution that is FDA-compliant and HITRUST-certified, Galen Data allows medical device companies to concentrate on their core innovations without needing to become experts in software design, data storage, and regulatory compliance. This approach significantly reduces development time, costs, and risks associated with bringing new medical technologies to market, empowering healthcare providers to optimize collected information and drive future device innovation.
Ikonopedia
Series D in 2021
Ikonopedia, LLC is a developer of a cloud-based breast study interpretation and reporting system designed to enhance the efficiency of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that ensures compliance with the Mammography Quality Standards Act (MQSA) and offers customizable report macros for individual practitioners. Additionally, Ikonopedia's SonoPro application supports radiologists during diagnostic breast ultrasound exams. The solutions are designed to automate tracking and monitoring of patients, ensuring clear and consistent clinical reports that adhere to the ACR BI-RADS® Atlas 5th Edition. The system is compatible with various modern devices and is utilized by telemammography and satellite clinics, ultimately aiming to improve patient safety, streamline workflows, and enhance the overall experience for radiologists and their staff.
VenoStent
Seed Round in 2021
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, the company specializes in developing bioresorbable smart polymers specifically designed for vascular surgery. Its flagship product, SelfWrap, is a perivascular wrap that functions as an external stent to enhance the success of dialysis procedures. SelfWrap addresses complications at the vein-artery or vein-graft junction by promoting outward vein growth and providing customized mechanical support, thereby reducing the risk of vein collapse and occlusion. This innovative approach utilizes a new class of shape-memory polymers that do not require sutures, ultimately improving surgical outcomes, reducing operation time, and minimizing infection risks for hemodialysis patients. VenoStent aims to significantly impact the approximately 5 million vascular surgeries conducted annually, enhancing the quality and longevity of life for chronic kidney disease patients.
Allotrope Medical
Series A in 2021
Allotrope Medical Inc. is a Houston-based medical device company that specializes in manufacturing surgical devices aimed at enhancing surgical procedures. The company's flagship product, StimSite, is an intuitive handheld device designed specifically to assist surgeons in quickly and accurately identifying ureters during operations. This device not only aids in ureter localization but also functions as a blunt dissection tool, streamlining the surgical process. By employing a simple single-button design, Allotrope Medical's device eliminates the need for additional pre and post-operative procedures, thereby improving efficiency in pelvic surgeries. Established in 2016, the company focuses on innovative solutions that enhance surgical accuracy and patient safety.
Allotrope Medical
Convertible Note in 2020
Allotrope Medical Inc. is a Houston-based medical device company that specializes in manufacturing surgical devices aimed at enhancing surgical procedures. The company's flagship product, StimSite, is an intuitive handheld device designed specifically to assist surgeons in quickly and accurately identifying ureters during operations. This device not only aids in ureter localization but also functions as a blunt dissection tool, streamlining the surgical process. By employing a simple single-button design, Allotrope Medical's device eliminates the need for additional pre and post-operative procedures, thereby improving efficiency in pelvic surgeries. Established in 2016, the company focuses on innovative solutions that enhance surgical accuracy and patient safety.
VenoStent
Seed Round in 2020
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, the company specializes in developing bioresorbable smart polymers specifically designed for vascular surgery. Its flagship product, SelfWrap, is a perivascular wrap that functions as an external stent to enhance the success of dialysis procedures. SelfWrap addresses complications at the vein-artery or vein-graft junction by promoting outward vein growth and providing customized mechanical support, thereby reducing the risk of vein collapse and occlusion. This innovative approach utilizes a new class of shape-memory polymers that do not require sutures, ultimately improving surgical outcomes, reducing operation time, and minimizing infection risks for hemodialysis patients. VenoStent aims to significantly impact the approximately 5 million vascular surgeries conducted annually, enhancing the quality and longevity of life for chronic kidney disease patients.
Galen Data
Seed Round in 2019
Galen Data, Inc. is a healthcare technology company based in Houston, Texas, founded in 2016. It offers a configurable and scalable software platform designed for medical devices, enabling them to centralize and securely store data while leveraging cloud technologies. The platform facilitates data visualization and analytics, integrating seamlessly with major electronic health record systems. By providing a turn-key solution that is FDA-compliant and HITRUST-certified, Galen Data allows medical device companies to concentrate on their core innovations without needing to become experts in software design, data storage, and regulatory compliance. This approach significantly reduces development time, costs, and risks associated with bringing new medical technologies to market, empowering healthcare providers to optimize collected information and drive future device innovation.
Zibrio
Convertible Note in 2019
Zibrio is a balance diagnostics company based in Houston, Texas, founded in 2017. The company specializes in developing technology that utilizes expertise in postural control and machine learning to detect subtle changes in balance. Originally derived from NASA technology used for astronauts returning from space, Zibrio's innovations aim to enhance health management by providing users with insights into their balance profiles. The company's devices help individuals monitor their balance and weight, offering personalized assistance and recommendations to improve balance, reduce the risk of falls, and ultimately enhance overall health outcomes.
Allotrope Medical
Convertible Note in 2019
Allotrope Medical Inc. is a Houston-based medical device company that specializes in manufacturing surgical devices aimed at enhancing surgical procedures. The company's flagship product, StimSite, is an intuitive handheld device designed specifically to assist surgeons in quickly and accurately identifying ureters during operations. This device not only aids in ureter localization but also functions as a blunt dissection tool, streamlining the surgical process. By employing a simple single-button design, Allotrope Medical's device eliminates the need for additional pre and post-operative procedures, thereby improving efficiency in pelvic surgeries. Established in 2016, the company focuses on innovative solutions that enhance surgical accuracy and patient safety.
VenoStent
Pre Seed Round in 2019
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, the company specializes in developing bioresorbable smart polymers specifically designed for vascular surgery. Its flagship product, SelfWrap, is a perivascular wrap that functions as an external stent to enhance the success of dialysis procedures. SelfWrap addresses complications at the vein-artery or vein-graft junction by promoting outward vein growth and providing customized mechanical support, thereby reducing the risk of vein collapse and occlusion. This innovative approach utilizes a new class of shape-memory polymers that do not require sutures, ultimately improving surgical outcomes, reducing operation time, and minimizing infection risks for hemodialysis patients. VenoStent aims to significantly impact the approximately 5 million vascular surgeries conducted annually, enhancing the quality and longevity of life for chronic kidney disease patients.
Ikonopedia
Series C in 2019
Ikonopedia, LLC is a developer of a cloud-based breast study interpretation and reporting system designed to enhance the efficiency of radiologists. Established in 2012 and headquartered in Dallas, Texas, the company provides a comprehensive Mammography Reporting System that ensures compliance with the Mammography Quality Standards Act (MQSA) and offers customizable report macros for individual practitioners. Additionally, Ikonopedia's SonoPro application supports radiologists during diagnostic breast ultrasound exams. The solutions are designed to automate tracking and monitoring of patients, ensuring clear and consistent clinical reports that adhere to the ACR BI-RADS® Atlas 5th Edition. The system is compatible with various modern devices and is utilized by telemammography and satellite clinics, ultimately aiming to improve patient safety, streamline workflows, and enhance the overall experience for radiologists and their staff.
TeVido BioDevices
Venture Round in 2019
TeVido BioDevices, Inc. is a biotech start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Established in 2016, the company utilizes a platform technology that integrates 3D bio-printing with patients' living cells to create custom grafts. These grafts specifically address unmet needs in reconstructive and cosmetic surgery, particularly for individuals who have lost skin color due to scarring or disease. TeVido's approach aims to enhance the quality of life and self-esteem of those affected by disfigurement while also having potential applications in wound healing and broader cosmetic procedures. Through its advanced manufacturing techniques and cellular therapy innovations, TeVido BioDevices is poised to significantly improve surgical outcomes in the field of reconstructive medicine.
ClearCam
Seed Round in 2018
ClearCam Inc. is a medical technology company based in Austin, Texas, founded in 2018. It specializes in developing innovative tools that enhance visibility for surgeons during laparoscopic procedures. The company's flagship product, the ClearCam Kelling, is a laparoscope lens cleaning device designed to maintain a clear visual field without necessitating the removal of the laparoscope from the surgical site. This device attaches directly to the scope and does not require additional supplies, thereby streamlining surgical processes, saving time, and improving overall safety for patients and medical staff alike.
TeVido BioDevices
Seed Round in 2018
TeVido BioDevices, Inc. is a biotech start-up based in Austin, Texas, focused on developing innovative tissue-engineered products for reconstructive surgery. Established in 2016, the company utilizes a platform technology that integrates 3D bio-printing with patients' living cells to create custom grafts. These grafts specifically address unmet needs in reconstructive and cosmetic surgery, particularly for individuals who have lost skin color due to scarring or disease. TeVido's approach aims to enhance the quality of life and self-esteem of those affected by disfigurement while also having potential applications in wound healing and broader cosmetic procedures. Through its advanced manufacturing techniques and cellular therapy innovations, TeVido BioDevices is poised to significantly improve surgical outcomes in the field of reconstructive medicine.
DNAtrix
Convertible Note in 2016
DNAtrix, Inc. is a clinical-stage biotechnology company based in Houston, Texas, with an additional office in San Diego, California. The company specializes in developing virus-driven immunotherapies for cancer treatment, focusing initially on glioblastoma, a highly aggressive and currently untreatable brain tumor. Its lead product, DNX-2401, is a modified oncolytic virus derived from a common cold virus, designed to selectively target and kill cancer cells. This innovative approach has shown promising results, with over 35 patients treated and positive early outcomes reported. In addition to DNX-2401, DNAtrix is advancing other candidates such as DNX-2440 and DNX-2450 for solid tumors, as well as MYX-135 for hematological malignancies. The company also has a strategic partnership with Valo Therapeutics, further enhancing its research and development capabilities in the field of cancer immunotherapy.
Infrastructure Networks
Venture Round in 2016
Infrastructure Networks provides services for the acquisition and delivery of natural energy resources required to power a modern economy. It eliminates the frustrations associated with managing and scaling remote communications by providing end-to-end customer connectivity solutions. By leveraging the global scale and adoption of a leading standards-compliant technology, recognized technology leaders, along with 24/7 monitoring and boots-on-ground service, INET delivers “Wireless Infrastructure-as-a-Service” (W-Iaas) over the industry’s first end-to-end, private, LTE network. The company was founded in 2011 and is based in Houston, Texas.
Adient Medical
Series C in 2016
Adient Medical Inc. is a company focused on the development and delivery of absorbable medical devices, specifically designed to prevent pulmonary embolism. Founded in 2012 and headquartered in Pearland, Texas, Adient Medical's flagship product is an absorbable vascular filter that provides an effective solution for patients at risk of this condition. The company operates on the principle that implants should remain safe and effective throughout their useful lifespan and then dissolve without the need for surgical removal, thereby minimizing the risk of complications and reducing healthcare costs associated with removal procedures. Through its innovative approach, Adient Medical aims to enhance patient safety and improve outcomes in vascular care.
Adient Medical
Seed Round in 2015
Adient Medical Inc. is a company focused on the development and delivery of absorbable medical devices, specifically designed to prevent pulmonary embolism. Founded in 2012 and headquartered in Pearland, Texas, Adient Medical's flagship product is an absorbable vascular filter that provides an effective solution for patients at risk of this condition. The company operates on the principle that implants should remain safe and effective throughout their useful lifespan and then dissolve without the need for surgical removal, thereby minimizing the risk of complications and reducing healthcare costs associated with removal procedures. Through its innovative approach, Adient Medical aims to enhance patient safety and improve outcomes in vascular care.
Set.fm
Convertible Note in 2015
Set.fm, Inc. is an Austin, Texas-based company that operates an innovative online platform enabling live concert performers to capture and sell their performances immediately after the event. Established in 2012 and formerly known as DejaSet, Inc., Set.fm provides musicians with a user-friendly mobile app that allows them to record high-quality audio of their live shows, often using equipment they already possess. This technology facilitates the promotion and sale of recordings, giving artists an opportunity to generate additional revenue streams. Fans can purchase recordings of performances they attended, enhancing their experience and allowing them to relive the event long after it has concluded. Set.fm aims to support musicians and enrich the live music experience for fans worldwide.
DNAtrix, Inc. is a clinical-stage biotechnology company based in Houston, Texas, with an additional office in San Diego, California. The company specializes in developing virus-driven immunotherapies for cancer treatment, focusing initially on glioblastoma, a highly aggressive and currently untreatable brain tumor. Its lead product, DNX-2401, is a modified oncolytic virus derived from a common cold virus, designed to selectively target and kill cancer cells. This innovative approach has shown promising results, with over 35 patients treated and positive early outcomes reported. In addition to DNX-2401, DNAtrix is advancing other candidates such as DNX-2440 and DNX-2450 for solid tumors, as well as MYX-135 for hematological malignancies. The company also has a strategic partnership with Valo Therapeutics, further enhancing its research and development capabilities in the field of cancer immunotherapy.
Deep Imaging Technologies
Venture Round in 2014
Deep Imaging Technologies, Inc. is a subsurface imaging company established in 2008 and located in Tomball, Texas. The company specializes in developing advanced data collection equipment and software technologies tailored for the oil and gas industry. Its product offerings include surface imaging systems that utilize electromagnetic fields generated at very low frequencies to effectively image geological features. The combination of transmitters, receivers, and imaging software positions Deep Imaging Technologies as a key player in enhancing subsurface data acquisition and interpretation within the sector.
Cinegif
Seed Round in 2013
Cinegif is a software development company based in Austin, Texas, specializing in a patented video conversion technology that enables the creation of animated GIFs from still images and video. This innovative platform is designed to assist marketers and advertisers in enhancing their digital strategies by allowing them to communicate effectively without the constraints of traditional video formats, such as large file sizes and complexity. Cinegif's tools are utilized by branding professionals, email marketing firms, and web hosting companies to engage customers across various digital channels, including websites, social media, email, text messages, and digital signage. By providing a streamlined solution for animated content, Cinegif helps clients connect more meaningfully with their target audiences.